Name | Number of supported studies | Average coverage | |
---|---|---|---|
neuron | 9 studies | 56% ± 29% | |
glutamatergic neuron | 9 studies | 37% ± 21% | |
fibroblast | 6 studies | 20% ± 5% | |
connective tissue cell | 6 studies | 33% ± 11% | |
GABAergic neuron | 6 studies | 37% ± 12% | |
interneuron | 5 studies | 41% ± 25% | |
myofibroblast cell | 4 studies | 25% ± 11% | |
pericyte | 4 studies | 22% ± 5% | |
smooth muscle cell | 4 studies | 31% ± 13% | |
retinal ganglion cell | 4 studies | 81% ± 28% | |
amacrine cell | 4 studies | 55% ± 25% | |
pancreatic A cell | 3 studies | 34% ± 7% | |
endothelial cell | 3 studies | 25% ± 3% | |
OFF-bipolar cell | 3 studies | 51% ± 35% | |
retina horizontal cell | 3 studies | 37% ± 24% | |
oligodendrocyte precursor cell | 3 studies | 38% ± 15% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 99% | 6782.03 | 2606 / 2642 | 100% | 125.71 | 703 / 705 |
adrenal gland | 93% | 992.47 | 239 / 258 | 78% | 110.90 | 180 / 230 |
uterus | 95% | 1281.97 | 161 / 170 | 53% | 22.77 | 241 / 459 |
bladder | 95% | 670.43 | 20 / 21 | 50% | 16.10 | 252 / 504 |
thymus | 91% | 717.47 | 593 / 653 | 52% | 8.94 | 316 / 605 |
lung | 89% | 660.91 | 516 / 578 | 49% | 18.48 | 568 / 1155 |
esophagus | 86% | 669.44 | 1247 / 1445 | 44% | 14.33 | 80 / 183 |
ovary | 86% | 1239.28 | 154 / 180 | 43% | 7.06 | 187 / 430 |
skin | 54% | 360.58 | 980 / 1809 | 58% | 20.03 | 273 / 472 |
breast | 55% | 368.40 | 251 / 459 | 50% | 8.89 | 556 / 1118 |
prostate | 91% | 785.98 | 224 / 245 | 7% | 0.90 | 36 / 502 |
intestine | 88% | 959.37 | 849 / 966 | 9% | 1.57 | 47 / 527 |
spleen | 95% | 871.54 | 230 / 241 | 0% | 0 | 0 / 0 |
heart | 90% | 1576.18 | 771 / 861 | 0% | 0 | 0 / 0 |
pancreas | 27% | 145.04 | 87 / 328 | 56% | 9.35 | 100 / 178 |
blood vessel | 82% | 831.93 | 1099 / 1335 | 0% | 0 | 0 / 0 |
stomach | 65% | 645.81 | 235 / 359 | 14% | 2.31 | 39 / 286 |
muscle | 79% | 995.88 | 634 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 77% | 811.45 | 713 / 929 | 0% | 0 | 0 / 0 |
kidney | 46% | 303.85 | 41 / 89 | 11% | 2.35 | 96 / 901 |
adipose | 42% | 295.80 | 509 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 24% | 3.50 | 11 / 45 |
liver | 5% | 31.11 | 11 / 226 | 17% | 3.68 | 67 / 406 |
lymph node | 0% | 0 | 0 / 0 | 10% | 1.46 | 3 / 29 |
eye | 0% | 0 | 0 / 0 | 1% | 0.46 | 1 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0090200 | Biological process | positive regulation of release of cytochrome c from mitochondria |
GO_0097191 | Biological process | extrinsic apoptotic signaling pathway |
GO_0097193 | Biological process | intrinsic apoptotic signaling pathway |
GO_0051901 | Biological process | positive regulation of mitochondrial depolarization |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_0005813 | Cellular component | centrosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005515 | Molecular function | protein binding |
GO_0003674 | Molecular function | molecular_function |
Gene name | MLLT11 |
Protein name | Protein AF1q Alternative protein MLLT11 |
Synonyms | hCG_1778767 AF1Q |
Description | FUNCTION: Cofactor for the transcription factor TCF7 . Involved in regulation of lymphoid development by driving multipotent hematopoietic progenitor cells towards a T cell fate . . |
Accessions | Q13015 Q6FGF7 ENST00000368921.5 L8E9A9 |